+Vote!
The Earth Times Online Newspaper (Free subscription) | 24/11/2008
... to be involved in bringing this important product to market,” said Biovail Chief Executive Officer Bill Wells. “Xenazine® is the first commercial product stemming from our New Strategic Focus – one that targets unmet medical needs in specialty central nervous system, or CNS markets.” Xenazine® will be distributed throughout the United States via a specialty pharmacy network. This...
+Vote!
The Earth Times Online Newspaper (Free subscription) | 24/11/2008
... to be involved in bringing this important product to market,” said Biovail Chief Executive Officer Bill Wells. “Xenazine® is the first commercial product stemming from our New Strategic Focus – one that targets unmet medical needs in specialty central nervous system, or CNS markets.” Xenazine® will be distributed throughout the United States via a specialty pharmacy network. This...
+Vote!
Red Orbit (Free subscription) | 07/11/2008
... to 2007, he served as vice president and global therapeutic area head of neuroscience for Amgen. Bill Wells, Biovail's CEO and president of Biovail Laboratories International, said: "As chief scientific officer, Dr Fibiger will oversee and have ultimate responsibility for the company's development pipeline. His expertise in neurosciences, in conjunction with his pharmaceutical industry...
+Vote!
Business Wire (Free subscription) | 06/11/2008
... Focus and in restructuring our business in the third quarter” said Biovail Chief Executive Officer Bill Wells. “We acquired our first specialty CNS product, which we expect to launch under the brand name Xenazine® in the United States this year. Xenazine® is the only product approved for the treatment of Huntingtons Chorea in the U.S. and we are delighted to be part of bringing this...
+Vote!
SeekingAlpha Energy Stocks (Free subscription) | 04/11/2008
Rowan Companies Inc. ()Q3 2008 Earnings Call TranscriptNovember 4, 2008 9:30 am ETExecutivesSuzanne McLeod - IRDanny McNease - Chairman and CEOBill Wells - CFOAnalystsJames West - Barclays CapitalRob MacKenzie - FBR Capital MarketsKurt Hallead - RBC Capital MarketsDan Pickering - Tudor, Pickering, Holt & Co.Ian MacPherson - Simmons &CompanyArun Jayaram - Credit SuisseRobin Shoemaker -...
+Vote!
CoffeeGeek.com (Free subscription) | 02/11/2008
I wanted an inexpensive HX machine for work, something that would work well but also something that I would not feel despondent should it go walking. The Gaggia Baby I was using was definitely inexpensive and low-profile, but it was limited in performance. The BZ02S fits the bill well.I like the design. I appreciate stainless steel and chrome, but it gets to be overkill after a...
1Vote!
Mirror.co.uk (Free subscription) | 28/10/2008
Spurs are left facing a total compensation bill well in excess of £15m for sacking Ramos and assistants Gus Poyet and Marcos Alvarez, as well as sporting director Damien Comolli.
- send to a friend
-
Explore : England, Football, Football Executives, Football Managers, Gus Poyet, José María del Nido, José María del Nido, Juande Ramos, Sport, The Premier League, Tottenham
+Vote!
Cootiehog (Free subscription) | 28/10/2008
I could never get that other theme to work that I uploaded this past weekend, but I found this one and I like it a lot. I was seeking crisp and clean and this one fits the bill well enough. It’s red, which is a rare color around here. I tend to [...]
+Vote!
Unshelved (Free subscription) | 27/10/2008
Well we're down to the wire. Friday midnight is the deadline for submitting your entry to Pimp My Bookcart 2008 . We've already got a healthy 45 entries. We can't wait to see yours! Posted by Bill on 10/27/2008 10:25:00 AM
+Vote!
Bearded Magazine (Free subscription) | 30/10/2008
... lullaby-esque piano that dominates ‘Of your Feet, Of your Place’ could almost have been played by Bill Wells and lifted off Osaka Bridge . This is not to say that Nature’s Got Away might as well be a Maher Shalal Hash Baz record, far from it. There is no doubt that this is a Blau record and he has used one of his most prominent influences to develop a record that is purely individual...
